Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Geen hogere mortaliteit COVID-19 bij NSAID-gebruik
jan 2021 | Artrose, RA, Virale infecties